Jewell Christopher M 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Jewell Christopher M
Chief Scientific Officer
Transactions
- Award
Common Stock
[F1]2024-01-02+778,200→ 778,200 total - Award
Employee Stock Option (right to buy)
[F2]2024-01-02+998,000→ 998,000 totalExercise: $0.66Exp: 2034-01-01→ Common Stock (998,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028.
- [F2]This option vests as to 25% on January 2, 2025. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2028.
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Christopher Jewell|2024-01-04